Android app on Google Play

VIVUS (VVUS) Resumes Trading +17%

July 18, 2012 7:15 AM EDT Send to a Friend
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk, Trading Halts

Add Your Comment